However, the expression of ApoB and MTP are significantly low in the NASH patients compared to the patients with simple hepatic steatosis, suggesting possible impairment of TG secretions such as VLDL with the progression of steatosis into NASH [62]. Here, APOB is linked to metabolic dysfunction-associated steatohepatitis.